GLP1R and Parkinson disease: In the central nervous system (CNS), GLP-1R activation initiates a signaling cascade that inhibits the release of proinflammatory cytokines and microglia transformation, both key contributors to Parkinson’s and Alzheimer’s pathogenesis (Athauda and Foltynie, 2016; Cui et al., 2022).